How a UK Digital Health software company is providing electronic
medical records in Qatar
TPP is dedicated to revolutionising the healthcare sector in the UK and internationally to provide truly integrated, patient-centric care.
TPP is one of the UK’s leading healthcare technology companies dedicated to delivering software that is specially designed to support the effective, efficient and safe provision of healthcare.
The company is the pioneer of SystmOne – a complete clinical and administrative solution that enables health organisations to deliver truly integrated patient care through a single, shared Electronic Health Record (EHR), that is available in real time at the point of care. The innovative software enables data to be shared securely across health services to improve the patient experience and deliver safer and more standardised care.
SystmOne has been operational as a single, remotely-managed solution for 20 years and has the world’s largest online database, standing at 1.7 petabytes.
TPP is testament to the UK’s expertise in developing pioneering healthcare technology that is transforming lives.
The UK Government is dedicated to playing a leading role in the development of innovative technologies aimed at solving some of the most pressing global healthcare challenges. The UK medical technology sector is vibrant and growing, with 121,900 people employed in 3,583 businesses and a turnover of £22.2 billion. Many of the UK’s leading health technology companies, including TPP, are heavily engaged with the UK’s NHS – the world’s largest integrated health system which provides care to more than 60 million patients. The incredible scale and depth of data, and the collaborative nature of the NHS, supports in-depth research and innovation that is transforming the way that healthcare is delivered in the UK and abroad.
TPP is rapidly evolving the way that patients’ health records are stored and used by medical and care professionals across health services in the UK.
TPP is renowned for its outstanding achievements in UK healthcare, with more than 50 million NHS health records stored on its single database. The software provider is also leading the way in the NHS mandated ‘GP interoperability programme’ aimed at utilising pioneering technology for more effective medicines management and safer care across boundaries.
All data recorded on TPP systems is available for daily extraction. This is already widely used across the NHS for service evaluation, risk management and care insights. TPP is also deeply committed to UK health research and provides vital data and support to many national studies including the UK Biobank and Public Health England. For several years, TPP has provided a free system to assist universities with clinical informatics training. The programme, which was trialled at the University of Leeds, has grown to encompass several disciplines and has been extended to multiple education establishments across the country.
TPP is working closely with several GCC governments and companies to support their visions for more integrated care.
In 2016, TPP signed a collaboration agreement with Qatar-based holding company, Integrated Intelligence Solutions (IIS), to deliver the integrated electronic records software - SystmOne to private healthcare facilities across Qatar. The project, which is due to roll out over a five-year period, is the first of its kind in the country and is valued at 102 million Qatari Riyals. The collaboration will see TPP Middle East deliver the SystmOne clinical system to approximately 300 primary care sites across Qatar. This will result in a greater standardisation of patient care, whilst also ensuring that all patient information is collected more routinely.
The solutions provider has also partnered with the Supreme Committee for Delivery and Legacy to enhance the provision of healthcare to workers building stadiums for the 2022 FIFA World Cup in Qatar. SystmOne is currently being piloted in two clinics servicing the Qatar Foundation Stadium Project, and has already enabled medical staff to register more than 3,600 workers, while conducting nearly 3,000 consultations as they begin building a complete patient database. Immediate benefits of the project are appointment reminders by SMS and transferrable medical records to the workers’ home countries.
Speaking about the project, Ashley Brook, Director of TPP, said: "Our system supports the Supreme Committee to enhance the well-being of workers by ensuring regular health checks are carried out while offering instant access to key health reports and dashboards. These functions support the audit and compliance function of the SC's Workers' Welfare Department while monitoring the health of workers with risk factors, which we quickly understood to be a priority of the organisation."
Jinoos Shariarti, First Secretary and Director of Trade & Investment at the British Embassy in Qatar added: “The UK Government is committed to supporting Qatar in delivering a successful World Cup and implementing its ambitious National Vision 2030. TPP’s partnership with SCDL is an example of the UK’s world-leading expertise in Digital Health with the ability to transform and improve the provision of healthcare in the region.”
TPP is deeply committed to extending its support to GCC governments and firms to help tackle the unique healthcare challenges that exist in the region.
The GCC have some of the highest rates of non-communicable diseases in the world. According to a 2019 report by Qatar Biobank which studied more than 18,000 adult Qataris and long-term residents, 43% were found to be overweight or obese. Lifestyle diseases are one of the key drivers behind the growth of the healthcare market in the GCC, with Qatar’s spending on healthcare expected to double to $8.8 billion (USD) by 2020.
With one of the largest primary care databases in the world, TPP has unrivalled experience in using and understanding health data. The company is committed to working with government and academic organisations in Qatar, and the wider region, to utilise their statistics to better understand, and consequently tackle, national health challenges. Regarding lifestyle diseases, TPP can help governments and health and care organisations to reach key insights that can inspire real change within the prevention and treatment of diseases such as diabetes, certain types of cancer and obesity. TPP can also deliver patient-centric solutions that offer personalised support for long-term conditions, in addition to clinical apps that can assist in the early detection of non-communicable diseases.
TPP can also deliver patient-centric solutions that offer personalised support for long-term conditions, in addition to clinical apps that can assist in the early detection of non-communicable diseases.